Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 218.68B P/E 46.67 EPS this Y 11.80% Ern Qtrly Grth 20.90%
Income 6.33B Forward P/E 16.31 EPS next Y 40.90% 50D Avg Chg -
Sales 47.61B PEG 1.41 EPS past 5Y 19.90% 200D Avg Chg 3.00%
Dividend 4.00% Price/Book 35.19 EPS next 5Y 13.50% 52W High Chg -8.00%
Recommedations 1.70 Quick Ratio 0.70 Shares Outstanding 3.10B 52W Low Chg 34.00%
Insider Own 0.01% ROA 7.04% Shares Float 1.54B Beta 0.16
Inst Own 16.84% ROE 17.29% Shares Shorted/Prior 8.58M/7.66M Price 70.47
Gross Margin 82.50% Profit Margin 13.30% Avg. Volume 5,051,933 Target Price 82.74
Oper. Margin 26.11% Earnings Date Jul 25 Volume 5,274,006 Change -1.37%
About Astrazeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca PLC News
05/17/24 AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
05/16/24 AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
05/16/24 Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
05/16/24 AstraZeneca selects new heart failure target with BenevolentAI
05/13/24 PRESS DIGEST-British Business - May 14
05/13/24 UK pharma giants pledge Β£430m investment in France after Macron charm offensive
05/13/24 Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
05/13/24 Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
05/13/24 France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit
05/12/24 Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
05/10/24 Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
05/10/24 Catalyst's New CEO Has Big Ideas For The Small Biotech
05/09/24 7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
05/08/24 Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
05/08/24 Every household should be forced to have a smart meter, says British Gas boss
05/08/24 AstraZeneca withdraws Covid-19 vaccine, citing low demand
05/08/24 Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
05/08/24 AstraZeneca withdraws COVID-19 vaccine, citing declining demand
05/08/24 AstraZeneca pulls its COVID-19 vaccine from the European market
05/08/24 AstraZeneca to withdraw Covid-19 vaccine globally
AZN Chatroom

User Image ShortyMcFly Posted - 6 hours ago

@SouthernItUp Damn, I knew it. Seemed so orchestrated front top down. Too many coincidences..πŸ₯ΌπŸš«πŸ§«πŸ’‰ $mrna $pfe $jnj $AZN $xbi etc #vaccines

User Image StockInvest_us Posted - 21 hours ago

Signal alert: $AZN - GoldenStar https://stockinvest.us/l/ueHau0b12m

User Image JxP2000 Posted - 1 day ago

$AZN nice pump, more!

User Image DefenseMania Posted - 1 day ago

Keep an eye on these presentations πŸ˜‰ $GILD $AMGN $AZN $PFE https://finance.yahoo.com/news/arcus-biosciences-present-data-phase-200000387.html

User Image StockInvest_us Posted - 1 day ago

Signal alert: $AZN - GoldenStar https://stockinvest.us/l/fdTKPUPtB8

User Image Outcomes Posted - 2 days ago

$PFE $MRNA $AZN $JNJ $NRXP mRNA BAD. Beware Big pharma. Beware Bureaucrats. Save the children. πŸ™ πŸ™ πŸ™ https://open.substack.com/pub/bestofdailyclout/p/pfizerfda-knew-in-early-2021-that?r=re3i2&utm_medium=ios

User Image Chipwars Posted - 2 days ago

$AZN https://finance.yahoo.com/news/astrazeneca-selects-heart-failure-target-102253308.html

User Image Chipwars Posted - 2 days ago

$AZN https://www.directorstalkinterviews.com/astrazenecas-sipavibart-shows-promising-results-in-covid-19-prevention-trial/4121156897

User Image Chipwars Posted - 2 days ago

$AZN https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-investigational-covid-drug-meets-primary-goals-late-stage-study-2024-05-16/

User Image Chipwars Posted - 2 days ago

$AZN smart move from Astrazeneca : https://www.fiercebiotech.com/biotech/astrazeneca-prepares-fresh-covid-push-regulators-after-antibodys-phase-3-success

User Image DefenseMania Posted - 2 days ago

$ABBV fueling like a big biotech merger is brewing $AZN + $GILD ? $AMGN $PFE

User Image 100dollars Posted - 2 days ago

$IBRX $MRK $AZN $NVS $BMY come to mama

User Image DonCorleone77 Posted - 2 days ago

$AZN AstraZeneca reports SUPERNOVA trial of sipavibart met COVID prevention endpoint "Positive" high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis trial showed AstraZeneca's sipavibart, formerly AZD3152, an investigational long-acting antibody, demonstrated a statistically significant reduction in the incidence of symptomatic COVID-19 compared to control in an immunocompromised patient population. The trial met both dual primary endpoints; the first one being the relative risk reduction of symptomatic COVID-19 caused by any SARS-CoV-2 variant and the second being the relative risk reduction of infections caused by SARS-CoV-2 variants not containing the F456L mutation. SUPERNOVA demonstrated the potential benefit of sipavibart in an evolving variant landscape in which COVID-19 cases captured over the course of the trial were caused by several different SARS-CoV-2 variants, the company announced.

User Image 100dollars Posted - 2 days ago

$IBRX who will be the sole owner of this $MRK 131 $AZN 77 $NVS 103 $BMY 44

User Image MrsBelfort Posted - 3 days ago

$MRNA $PFE $AZN For these big pharma, potential acquisition candidates for their due diligence teams to look at: $CADL $CAPR Candel is getting expensive but Capricor is still quite cheap.

User Image Teleboy Posted - 3 days ago

$AIM It has been a couple of weeks so here's an update: Excellent interim data from both the combo $AZN Pancreatic trial and the combo $MRK UPitt recurrent Ovarian; other positive updates from TNBC, Melanoma, and the Dutch trial's Pancreatic dosing safety data. Also a large batch of Ampligen was manufactured. Conference call May 16 at 0830 Awaiting news on the following: 1. Detailed UPitt ovarian cancer data update due Q2 NCT03734692 (phase 1 and 2) 2. Takeover/licensing negotiations progress. 3. TNBC final trial results with Keytruda and Celebrex $PFE NCT03599453 (phase 1) 4. Pancreatic cancer trial updates 5. Detailed Long-Covid Trial data

User Image TheWhale_CYDY Posted - 4 days ago

$CYDY $PFE $AZN $MRNA https://www.instagram.com/lennieboy/reel/C68zrSIuXkr/

User Image DameWave Posted - 5 days ago

$FBIO How long can this go on? If you buy shares in FBIO now, you get 53% of DERM, $7 M (because 53% of DERM is valued $7 M higher than the entire FBIO) and the remaining portfolio below valued at $0. Again, $0... In addition to the ownership %, FBIO has a 2.5% annual equity dividend and 4.5% royalty in almost all below... * = Deals made - Helocyte – 83% - Cellvation – 79% - Oncogenuity – 79% - *Cyprium – 74% (PRV $110 M + $20 M approval and eligible to receive sales milestones totaling up to $129 M and tiered royalties: 3.00% of net sales up to $75 M, 8.75% between $75 M and $100 M, 12.50% over $100 M up to $255-275 M in total) - Urica – 68% - *Caelum – 42% ($31,8 M on approval and up to ~$150 M in future proceeds from $AZN deal) - *Aevitas - ? (eligible to ~$140 M in potential late-stage development, regulatory and sales milestone payments plus royalties from $FDMT) - Mustang – 21% Checkpoint – 11% - Avenue – 4% $XBI $IBB

User Image tradethehalt Posted - 5 days ago

$AMZN $AZN $MSFT Tech giants announce multi-billion investments in French market https://www.reuters.com/technology/amazon-invest-13-bln-france-create-3000-jobs-2024-05-13/

User Image vipbackchannel Posted - 6 days ago

$MNRA $PFE $AZN https://twitter.com/toobaffled/status/1789742602386112584

User Image Doozio Posted - 6 days ago

$AZN a πŸ§ πŸ‘€ is now 🧠⏰ ready to run like IESC newton!!

User Image NewsByNick Posted - 6 days ago

(Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit. $PFE $AZN https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-astrazeneca-announce-new-investments-nearly-1-billion-france-2024-05-12/

User Image Outcomes Posted - 1 week ago

$PFE $MRNA $JNJ $AZN $NRXP Beware Big pharma. Clinical trials matter. Outcomes matter. https://www.linkedin.com/posts/vejon-health-ltd_i-would-never-put-another-vaccine-in-activity-7194817633005846528-beed?utm_source=share&utm_medium=member_desktop

User Image TheWhale_CYDY Posted - 1 week ago

$CYDY about to save the world from $MRNA $PFE $AZN $JNJ

User Image DeepDown Posted - 1 week ago

$ALLR one of the big pharma with parp drugs will pick this up. $AZN , $MRK , or $GSK

User Image Bull_shift Posted - 1 week ago

$NVAX AstraZeneca and Pfizer: left the chat. πŸ₯± people still vaxing? πŸ‘€ $SPY $PFE $AZN $MRNA

User Image StockInvest_us Posted - 1 week ago

Signal alert: $AZN - GoldenStar https://stockinvest.us/l/VtuDDAiNrY

User Image DefenseMania Posted - 1 week ago

$GILD take a look at RCUS earnings report !!! Wake up folks !!! $AZN $ABBV $AMGN $PFE GILD purchased 33% of the float in late January at $21.00 per share

User Image StockednLoaded Posted - 1 week ago

$IOVA - The pharma's $ABBV and $AZN who previously acquired Wayne's previous two largest holdings (pharmacyclics/acerta) have gone on to add a combined 300B to their market caps in the last 7 years. Who wants to be next?

User Image alexsimonelis Posted - 1 week ago

$SPY $QQQ This is definitely not good -> $AZN https://www.telegraph.co.uk/news/2024/05/07/astrazeneca-withdrawing-covid-vaccine/

Analyst Ratings
BMO Capital Outperform Apr 26, 24
Deutsche Bank Hold Apr 16, 24
BMO Capital Outperform Feb 12, 24
Deutsche Bank Hold Feb 8, 24
Morgan Stanley Overweight Jan 23, 24
Jefferies Hold Jan 3, 24
Jefferies Buy Sep 25, 23
Erste Group Hold Sep 8, 23
BMO Capital Outperform Aug 1, 23